About SpePharm
SpePharm is a European specialty pharmaceutical company dedicated to acquiring, registering and marketing high medical value medicines throughout Europe, essentially for the hospital market.
The SpePharm management team has a wealth of global experience within the pharmaceutical industry. In particular, the team has a well-established and in-depth knowledge of the European regulatory system, the hospital market, and niche and orphan products, with novel approaches and proven successes. SpePharm intends to use this proven expertise to register and commercialize its own products in Europe, as well as those of its partners. Its goal is to become a leading European specialty pharmaceutical company focused on the hospital market.
The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA).
SpePharm, as SpePharm Holding BV, has its headquarters in Amsterdam, The Netherlands, and operations are run from its French subsidiary, SpePharm SAS France, in Paris, France.
- Focus : Manufacturer
- Industry : Pharma
